MedTech News
.................... by Andrew Celentano
Daré’s CEO Wants Everyone To Invest in Women’s Health, Starting With Her Company
Sabrina Martucci Johnson wants everyone to invest in her women’s health biotech Daré Bioscience. That means you, dear reader.
FDA approves Endospan’s aortic stent
Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around 25% of patients are diagnosed or treated.
Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.
BD picks up CE mark for next-gen stent graft
BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system.
Supira gets FDA green light to conduct ventricular assist device study
Supira Medical announced today that it received FDA approval to initiate a new trial of its percutaneous ventricular assist device (pVAD).
MRI technique enables long-term tracking of transplanted stem cell-derived heart cells
Researchers at the Institute of Biomedical Engineering at the University of Toronto have demonstrated a new way to monitor transplanted stem-cell-derived heart cells using magnetic resonance imaging (MRI).
Gene-edited stem cells help five blood disorder patients stop transfusions in clinical trial
Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia.
Sequencing method exposes hidden gaps in immune signaling by tracking RNA and protein together
A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity.